Medical management of women with rheumatic diseases during pregnancy is challenging owing to incomplete information regarding medication safety. The British Society for Rheumatology and the British Health Professionals in Rheumatology committee published consensus guidelines that provide a good first step towards narrowing the knowledge gap in this important field.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Østensen, M. et al. State of the art: reproduction and pregnancy in rheumatic diseases. Autoimmun. Rev. 14, 376–386 (2015).
Kavanaugh, A. et al. Proceedings from the American College of Rheumatology Reproductive Health Summit: the management of fertility, pregnancy, and lactation in women with autoimmune and systemic inflammatory diseases. Arthritis Care Res. (Hoboken) 67, 313–325 (2015).
Flint, J. et al. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding — part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids. Rheumatology (Oxford) http://dx.doi.org/10.1093/rheumatology/kev404 (2016).
Flint, J. et al. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding — part II: analgesics and other drugs used in rheumatology practice. Rheumatology http://dx.doi.org/10.1093/rheumatology/kev405 (2016).
Källén, B. & Reis, M. Use of tramadol in early pregnancy and congenital malformation risk. Reprod. Toxicol. 58, 246–251 (2015).
Molgaard-Nielsen, D. & Hviid, A. Newer-generation antiepileptic drugs and the risk of major birth defects. JAMA 305, 1996–2002 (2011).
Kumar, M., Ray, L., Vemuri, S. & Simon, T. A. Pregnancy outcomes following exposure to abatacept during pregnancy. Semin. Arthritis Rheum. 45, 351–356 (2015).
Van der Woude, C. J. et al. The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease. J. Crohns Colitis 9, 107–124 (2015).
Salinas, M. A. et al. Clinical practice guidelines for the management of pregnancy in women with autoimmune rheumatic diseases of the Mexican College of Rheumatology. Part I. Reumatol. Clin. 11, 295–304 (2015).
Skorpen, A. C. & Østensen, M. Points to consider for use of antirheumatic drugs before and during pregnancy and lactation: progress of a EULAR task force [abstract THU0132]. Ann. Rheum. Dis. 74 (Suppl. 2), 242 (2015).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
B.L.B. has received consultancy honoraria from UCB. L.R.S. declares no competing interests.
Rights and permissions
About this article
Cite this article
Sammaritano, L., Bermas, B. A fine conception — BSR/BHPR guidelines on drugs in pregnancy. Nat Rev Rheumatol 12, 197–198 (2016). https://doi.org/10.1038/nrrheum.2016.27
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2016.27
